Yu Li

Dr. Yu Li

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2025 in The Spine Journal
Verified
Journal Article
Closed access
YLYu Li
Yu Li
KWKairo Wada
Kairo Wada
KWKanichiro Wada
Kanichiro Wada
TNTakaaki Nakano
Takaaki Nakano
GKGentaro Kumagai
Gentaro Kumagai
YIYasuyuki Ishibashi
Yasuyuki Ishibashi

7 April 2025 in BioMedical Engineering OnLine
Verified
Journal Article
Open access
PDF file
ZQZhichao Qi
Zhichao Qi
GYGuozhu Ye
Guozhu Ye
ZLZhiyi Liu
Zhiyi Liu
JZJie Zhang
Jie Zhang
WXWeidong Xie
Weidong Xie
WYWenbin Yang
Wenbin Yang
Introduction: Osteoporotic vertebral fractures are a common outcome of osteoporosis, imposing a substantial economic burden. The development of reliable animal models is essential for advancing research. This review examines osteoporotic vertebral fracture models across various animal species. Methods: The review compares and analyzes the different approaches used to model osteoporotic vertebral fractures in experimental animals, synthesizing the existing design protocols. Results: Rats and sheep are the primary experimental animals utilized in vertebral fracture research. The predominant approach in model design remains the creation of bone defects to simulate vertebral fractures. The spontaneous fracture model is primarily applicable to small species, such as transgenic mice. Rabbits and zebrafish are not suitable for modeling vertebral fractures due to the low cancellous bone content in their lumbar. The bone loss in the lumbar cancellous bone of the dog osteoporosis model is minimal, making it unsuitable for fracture modeling. Conclusions: The bone defect model remains the most widely used approach for osteoporotic vertebral fractures. However, the stress compression model shows promise as a potential focal point for future investigations.

9 January 2026 in Medicine
Verified
Journal Article
Open access
WZWeizheng Zeng
Weizheng Zeng
YLYu Li
Yu Li
YZYuliang Zhang
Yuliang Zhang
XLxizhe liu
xizhe liu
SLShaoyu Liu
Shaoyu Liu
Ankylosing spondylitis (AS) represents a significant global health challenge, characterized by progressive stiffness and rigidity of the axial skeleton and sacroiliac joints, which severely impact patients’ daily activities. Despite the availability of various therapeutic options, a substantial proportion of AS patients remain inadequately managed, underscoring the urgent need for novel treatment strategies. This study aimed to identify potential therapeutic targets for AS by investigating the association between circulating plasma proteins and the risk of developing AS. We conducted a comprehensive protein-wide Mendelian randomization analysis to assess the potential causal relationship between plasma proteins and the risk of AS. Plasma protein data were sourced from the UK Biobank Pharma Proteomics Project, which encompasses genome-wide association study data for 2940 plasma proteins. Additionally, genome-wide association study data for spondylosis were obtained from the Finnish R9 database. Colocalization analysis was performed to identify shared causal variants between plasma proteins and AS. Our findings indicated that the predicted plasma levels of 4 proteins were positively associated with the risk of spondylosis ( P FDR < .05). Among these 4 plasma proteins, colocalization analysis suggested that they share common variants with spondylosis (PPH3 + PPH4 > 0.5), highlighting their potential as direct therapeutic targets for intervention. This study explores the potential causal relationships between 4 plasma proteins and AS, contributing to the understanding of potential therapeutic targets for this condition.

1 October 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JPJiayin Pang
Jiayin Pang
YLYu Li
Yu Li
ZQZhichao Qi
Zhichao Qi
WYWenbin Yang
Wenbin Yang
Osteoarthritis and osteoporosis frequently coexist in older adults, but shared molecular programs remain unclear. We developed a disease-first multilayer public-data integration framework to identify shared protein candidates while preserving disease-specific structure before cross-disease comparison. Public bulk transcriptomic datasets from osteoarthritis synovium and cartilage and osteoporosis-related monocytes, femoral bone, and osteogenic stromal compartments were analyzed independently within each disease. Disease-level signatures were generated using differential expression analysis, robust rank aggregation, functional enrichment, and weighted gene co-expression network analysis. A shared axis was defined by concordant dysregulation, shared biological processes, and criteria-positive coexpression-module correspondences, with module matching subsequently calibrated against a size-preserving null model. Candidate genes were mapped to proteins and prioritized by integrating interaction topology, signaling priors, protein annotation, tissue support, disease-association and genetic evidence, local CARNIVAL virtual knockout, and single-cell contextual perturbation analysis. Both diseases showed reproducible signatures enriched in antigen presentation, cytokine regulation, extracellular matrix organization, osteoclast differentiation, ossification, and bone remodeling. Cross-disease comparison yielded 234 criteria-positive module pairs; 53 retained pair-specific support at empirical FDR < 0.05, whereas the total number of criteria-positive pairs did not exceed the global null expectation. Protein-level integration prioritized HLA-DRB1, HSP90AA1, CTSK, RPL7, PRG4, HLA-DRA, CLEC3B, TIMP1, SPP1, and APOE. Local virtual knockout assigned the highest model-derived CARNIVAL scores to HLA-DRB1 and HSP90AA1. Across the evaluated network configurations, HLA-DRB1 exceeded the prespecified score threshold in all four evaluable configurations, whereas HSP90AA1 exceeded it in four of six, indicating greater configuration stability for HLA-DRB1. Primary matched-null calibration of 39 evaluable candidate-compartment pairs retained nine pairs at global FDR < 0.05. External quality-control sensitivity analysis retained 125,090 of 161,470 cells and identified 10 globally FDR-supported pairs. Although only two of the nine primary pairs remained supported in the same compartment, five of the six primary supported genes retained evidence in at least one compartment. Recalculation using the quality-controlled cell-context evidence retained all primary top 10 proteins, with HLA-DRB1 and HSP90AA1 remaining the two highest-ranked candidates. Composition-aware bulk sensitivity analysis retained the direction of 36 of 40 candidate–cohort effects, while matched transcriptional-program adjustment retained 24 of 27 effects and showed greater attenuation of MHC-II candidates than of ribosomal or protein-folding candidates. These findings support a shared osteoimmune–matrix-remodeling protein axis linking osteoarthritis and osteoporosis and provide candidates for future experimental validation.

31 August 2026 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
YLYu Li
Yu Li
JPJiayin Pang
Jiayin Pang
ZQZhichao Qi
Zhichao Qi
WYWenbin Yang
Wenbin Yang
Impaired pulmonary function has been linked to lower bone mineral density and higher fracture risk, but longitudinal evidence on airway dysfunction and sub

30 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YLYu Li
Yu Li
GKGentaro Kumagai
Gentaro Kumagai
Sunao TanakaSunao Tanaka
Sunao Tanaka
KWKairo Wada
Kairo Wada
TNTakaaki Nakano
Takaaki Nakano
KWKanichiro Wada
Kanichiro Wada
Objectives: Diffuse idiopathic skeletal hyperostosis (DISH) is associated with cardiometabolic abnormalities, but its circulating immune-cell profile remains poorly characterized. This exploratory study examined immune-cell subsets and soluble inflammatory markers in relation to prevalent DISH. Method: Existing data from 526 participants in the 2021 Iwaki Health Promotion Project were analyzed using Firth-penalized logistic regression adjusted for age, sex, and visceral fat area. False-discovery-rate correction was applied jointly to eight immune-cell proportions and five inflammatory markers. Subsequent analyses characterized the CD16+CD56+ natural killer (NK)-cell association. Results: Forty-one participants had DISH. CD16+CD56+ NK-cell proportion was positively associated with DISH (OR per 10-percentage-point increase, 2.60; 95% CI, 1.81–3.73), whereas CD16−CD56− proportion was inversely associated (OR, 0.41; 95% CI, 0.29–0.58). Both associations remained significant after multiple-testing correction. Associations involving CD4+CD8− helper T cells and IL-6 were nominally significant but did not survive correction. Additional adjustment for smoking and alcohol use yielded a similar NK-cell estimate. Both NK-cell proportion and count were associated with DISH separately, but only the proportion remained significant when modeled together. Proportions differed across radiographic categories but were not associated with ossification burden among participants with DISH. Conclusions: DISH was associated with differences in circulating immune-cell proportions. These exploratory findings require independent confirmation and do not establish disease specificity, clinical biomarker utility, or a causal role in ossification.